載入...
Overall survival of stage IV non-small cell lung cancer patients treated with Viscum album L. in addition to chemotherapy, a real-world observational multicenter analysis
BACKGROUND: Stage IV non-small cell lung cancer (NSCLC) is associated with a five-year survival rate of around 1%. Treatment with Viscum album L. (VA) extracts has been shown to reduce chemotherapy (CTx)-related adverse events, decrease CTx dose reductions and improve quality of life in a number of...
Na minha lista:
| 發表在: | PLoS One |
|---|---|
| Main Authors: | , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Public Library of Science
2018
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6110500/ https://ncbi.nlm.nih.gov/pubmed/30148853 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0203058 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|